This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

SanMedica International™ Refuses To Disclose SeroVital™-hgh Celebrity Clientele

NEW YORK, March 27, 2013 /PRNewswire/ -- It's no secret that the rich and famous of Beverly Hills have been visiting some of the most expensive clinics in the world for controversial human growth hormone (hGH) therapy. Why? Because they believe hGH helps reduce body fat, increase lean muscle mass, boost mood, heighten sex drive, give them plenty of energy and get rid of wrinkles... making them look and feel decades — not years, but DECADES — younger. But now rumors are flying that rather than resorting to controversial, expensive, synthetic hGH injections, some celebrities are using a new growth hormone booster called SeroVital™-hgh. But SanMedica International™, SeroVital's distributor, is refusing to cough up the details.

"Of course we have people trying to convince us to release our client list," says Chantelle Daines, spokesperson for SanMedica. "That's inevitable whenever you're involved with celebrities. But we firmly believe that our customers — including the celebrities — are entitled to their privacy, and we are determined to respect that privacy."

Of course, any time celebs make something trendy, the media pays attention, and that has definitely held true for human growth hormone. It seems everyone's been talking about it. hGH has been featured on The Today Show, Good Morning America, Fox News, CNN, The Dr. Oz Show, and in Shape magazine and Vanity Fair. And even though SeroVital-hgh has only been available for about six months, it's already broken records in Parade magazine, been featured in Shape, on Radar Online, and on New York Live, been touted by makeup artists in magazines like Star and OK!... SeroVital has even been seen in the famed New York Times magazine.

But even before the rich and famous began getting their hands on SeroVital-hgh it was making headlines… in obesity research circles, believe it or not. The results of the double-blind, placebo-controlled clinical trial on SeroVital's highly specialized, proprietary, patent-pending key compound were presented for the first time at The Obesity Society's most recent Annual Scientific Meeting in San Antonio, Texas. At this exclusive conference, a group of some of the most renowned research scientists in the world revealed that this tiny little pill was actually capable of increasing mean, serum (blood) growth hormone levels... by an astounding 682%.

This was huge news, because up until this point the best way to increase our hGH levels was through expensive prescription injections (costs can run as high as $1500 per month). In addition to their high cost, these synthetic hGH injections are also extremely controversial, because some experts fear that introducing synthetic hGH into the body may upset the natural production of hGH.

That's what makes SeroVital-hgh so revolutionary. Rather than introducing synthetic hGH into the body like the injections, SeroVital raises the body's own, natural levels of human growth hormone by promoting pituitary health, the gland that manufactures hGH. SeroVital has not only made it more affordable for people to raise their hGH levels, but has given them a clinically proven way to raise them naturally.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,841.98 -86.22 -0.48%
S&P 500 2,080.15 -9.31 -0.45%
NASDAQ 4,919.6440 -19.6830 -0.40%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs